Schott Inaugurates New Prefillable Syringe Manufacturing Facility in Germany
Schott has announced the inauguration of its new high-end polymer prefillable syringe manufacturing facility in Mülheim, Germany.
Schott, a specialty glass company, has announced the inauguration of its new high-end polymer prefillable syringe manufacturing facility in Mülheim, Germany, in a May 6, 2022 press release. The company has invested millions in the new plant, which is reported to be providing more than 100 jobs for the region.
An R&D center has been included within the company’s investment, which will be used to drive rapid prototyping of new polymer syringe solutions for drug delivery. Additionally, the investment in the plant include a logistics and integrated administrative area, it was revealed in the press release.
“[The facility’s] opening marks a big step in our strategic business expansion,” said Andreas Reisse, executive vice-president of Schott’s Pharma business unit, in the press release. “The new facility in Müllheim aims to play an important role in supplying the global pharma industry with advanced drug delivery solutions made of polymer.”
Source: Schott
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
